Genetics Startup Aims to #39;Make 100 the New 60 #39;
J. Craig Venter, the man who helped map the human genome, is at it again. This time, the goal is to add decades onto everybody #39;s lives. J. Craig Venter, the ...

By: GeoBeats News

Read more:
Genetics Startup Aims to 'Make 100 the New 60' - Video

Recommendation and review posted by Bethany Smith

[FR][MINECRAFT][Mod] Advanced Genetics [1.7.2]
Le lien vers l #39;article de Minecraft-France: http://www.minecraft-france.fr/2014/03/mod-advanced-genetics-1-7-2/ En partenariat avec: http://www.youtube.com/w...

By: Killian Cartelier

See original here:
[FR][MINECRAFT][Mod] Advanced Genetics [1.7.2] - Video

Recommendation and review posted by Bethany Smith

HIV progress: Manipulating genes to reject virus
Using gene editing, researchers are trying to create HIV immunity. CBS News medical correspondent Dr. Jon LaPook explains the latest gene therapy.

By: CBS This Morning

Excerpt from:
HIV progress: Manipulating genes to reject virus - Video

Recommendation and review posted by Bethany Smith

Gene Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 201
Browse Full Report with TOC: http://www.transparencymarketresearch.com/gene-therapy-market.html - Gene therapy involves use of DNA as a pharmaceutical agent ...

By: Alina Martin

Follow this link:
Gene Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 201 - Video

Recommendation and review posted by Bethany Smith

Medical breakthrough: HIV gene therapy
U.S. scientists are using gene therapy for the first time to boost the immune system of people with HIV, which may help them in reducing the daily intake of ...

By: Romila De Munshi

See the original post:
Medical breakthrough: HIV gene therapy - Video

Recommendation and review posted by Bethany Smith

Scientists have modified genes in the blood cells of HIV patients to help them resist the AIDS virus, and say the treatment seems safe and promising. The results give hope that this approach might one day free at least some people from needing medicines to keep HIV under control, a form of cure.

The idea came from an AIDS patient who appears cured after getting a cell transplant seven years ago in Berlin from a donor with natural immunity to HIV. Only about 1 percent of people have two copies of the gene that gives this protection.

Researchers are seeking a more practical way to get similar results by using gene therapy to modify patients' own blood cells.

A study of this in 12 patients was led by Dr. Carl June at the University of Pennsylvania. Results are in Thursday's the New England Journal of Medicine. These are the first published results from this method, which also has been tried in several smaller studies of patients in California.

HIV usually infects blood cells through a protein on their surface, a "docking station" called CCR5. A California company, Sangamo BioSciences Inc., makes a treatment that can knock out a gene that makes CCR5.

The 12 HIV patients had their blood filtered to remove some of their cells. The gene-snipping compound was added in the lab, and the cells were infused back into the patients.

Four weeks later, half of the patients were temporarily taken off AIDS medicines to see the gene therapy's effect. The virus returned in all but one of them, but the modified cells seemed to be protected from HIV infection and were more likely to survive than the cells that had not been treated.

"We knew that the virus was going to come back in most of the patients," but the hope is that the modified cells eventually will outnumber the rest and give the patient a way to control viral levels without medicines, said Dr. Pablo Tebas, one of the Penn researchers. That would be what doctors call a "functional cure," because the virus would still be present but held in check without treatment.

The lone patient whose HIV did not return turned out to have one copy of the protective gene, so "nature had done half of the job already," Tebas said.

The National Institute of Allergy and Infectious Diseases sponsored the work with Sangamo and Penn.

Go here to see the original:
Gene therapy shows promise for HIV control

Recommendation and review posted by Bethany Smith

Cotswold Outdoor x Wings For Life
Cotswold Outdoor are going to be supporting Wings for Life in 2014. Wings for Life is a not-for-profit spinal cord research foundation. Their mission is to f...

By: Cotswold Outdoor

The rest is here:
Cotswold Outdoor x Wings For Life - Video

Recommendation and review posted by sam

stem cell therapy treatment for Spastic Paraplegia by dr alok sharma, mumbai, india
improvement seen in just 5 days after stem cell therapy treatment for Spastic Paraplegia by dr alok sharma, mumbai, india. Stem Cell Therapy done date 7/1/20...

By: Neurogen Brain and Spine Institute

Go here to see the original:
stem cell therapy treatment for Spastic Paraplegia by dr alok sharma, mumbai, india - Video

Recommendation and review posted by simmons

Google stem cell therapy and a whole host of results show up. Stem cell therapy for hair loss, diabetes, cancer and practically everything else. It is touted as the medicine of hope, the panacea for all ills.

But to ensure that this potentially-powerful technology is not misused in the country, the Indian Council of Medical Research has come up with a set of guidelines to regulate their use.

Under the new guidelines, any use of stem cells in patients will be considered research, not therapy.

This means stem cells can now only be used on patients within the purview of an approved, and monitored clinical trial anything outside of this would be considered malpractice. Ananthram Shetty, professor of minimally-invasive surgery at Canterbury Christ Church University, UK, said the guidelines are much-needed, welcome move in the right direction.

Prof. Shetty, who has been working with stem-cell technology for 27 years, and is often in India to demonstrate their use in research surgeries, said this would prevent anybody and everybody from claiming unproven benefits. Lots of people dont really understand what stem cells are. And those who have a terminal illness are willing to try anything. There are some people who use this to raise false hopes. And this is what the guidelines seek to stop, he said.

J.S. Rajkumar, chairman, Lifeline Hospital, however, said the guidelines could have been clearer about the use of adult stem cells over embryonic stem cells, he said. Now, the procedures involved and the time it would take could dissuade many, he said, while there is a real need for funds to be pumped in for research into this technology.

Another International Ear Care Day passed by on March 3.

It spelled out a clear message ear care can avoid hearing loss.

But the question is how many people know how to take care of their ears. What is interesting is the ear is a self-cleaning organ and does not require any kind of cleaning. But many clean their ears using safety pins, hair pins and even matchsticks.

While doctors advise against the use of such objects, they discourage the use of cotton buds too. Some heat coconut oil and pour into the ears. This could cause fungal infections. The ear drum is very thin and can be damaged, leading to loss of hearing, said M. Ramaniraj, professor of ENT, Government Stanley Medical College Hospital.

The rest is here:
Guidelines on use of stem cell therapy

Recommendation and review posted by simmons

Contact Information

Available for logged-in reporters only

Newswise March 7, 2014, Phoenix, AZ -- Stem cell transplant was viable and effective in halting or reversing degenerative disc disease of the spine, a meta-analysis of animal studies showed, in a development expected to open up research in humans. Recent developments in stem cell research have made it possible to assess its effect on intervertebral disc (IVD) height, Mayo Clinic researchers reported in a scientific poster today at the 30th Annual Meeting of the American Academy of Pain Medicine.

This landmark study draws the conclusion in pre-clinical animal studies that stem cell therapy for disc degenerative disease might be a potentially effective treatment for the very common condition that affects peoples quality of life and productivity, said the senior author, Wenchun Qu, MD, PhD, of the Mayo Clinic in Rochester, Minn.

Dr. Qu said not only did disc height increase, but stem cell transplant also increased disc water content and improved appropriate gene expression. These exciting developments place us in a position to prepare for translation of stem cell therapy for degenerative disc disease into clinical trials, he said.

The increase in disc height was due to restoration in the transplant group of the nucleus pulposus structure, which refers to the jelly-like substance in the disc, and an increased amount of water content, which is critical for the appropriate function of the disc as a cushion for the spinal column, the researchers concluded.

The researchers performed a literature search of MEDLINE, EMBASE and PsycINFO databases and also manually searched reference lists for original, randomized, controlled trials on animals that examined the association between IVD stem cell transplant and the change of disc height. Six studies met inclusion criteria. Differences between the studies necessitated the use of random-effects models to pool estimates of effect.

What they found was an over 23.6% increase in the disc height index in the transplant group compared with the placebo group (95% confidence interval [CI], 19.7-23.5; p<0.001). None of the 6 studies showed a decrease of the disc height index in the transplant group. Increases in the disc height index were statistically significant in all individual studies.

The authors commented that it is time to turn attention to the much-needed work of determining the safety, feasibility, efficacy of IVD stem cell transplant for humans.

A hallmark of IVD degenerative disease is its poor self-repair capacity secondary to the loss of IVD cells. However, current available treatments fail to address the loss of cells and cellular functions. In fact, many invasive treatments further damage the disc, causing further degeneration in the diseased level or adjacent levels, said the lead study author Jason Dauffenbach, DO. The goal of tissue engineering using stem cells is to restore the normal function and motion of the diseased human spine.

Read the original here:
Stem Cell Transplant Shows "Landmark" Promise for Treatment of Degenerative Disc Disease: Mayo Clinic

Recommendation and review posted by simmons

Contact Information

Available for logged-in reporters only

Newswise SEATTLE The Fred Hutchinson Bone Marrow Transplant Program at Seattle Cancer Care Alliance (SCCA) was recently recognized by the Center for International Blood and Marrow Transplant Research (CIBMTR) for outperforming its expected one-year survival rate for allogeneic transplant patients. The results published by the CIBMTR, analyzed the National Marrow Donor Programs (NMDP) registry of 168 U.S. transplant centers over a three-year period for its 2013 Transplant Center-Specific Survival Report.

The Fred Hutchinson Bone Marrow Transplant Program at SCCA pioneered the clinical use of bone marrow and stem cell transplantation more than 40 years ago and have performed more than 14,000 bone marrow transplants more than any other institution in the world. Today, the organization is one of just 13 stem cell transplant programs nationwide that exceeded its anticipated one-year survival rate for patients undergoing allogeneic transplants.

This type of transplant uses stem cells from a donor who may or may not be related to the patient. Stem cell transplants, including bone marrow transplants, are used to treat a range of leukemias and lymphomas, as well as other diseases such as severe aplastic anemia and sickle cell disease.

Comparing Transplant Centers

Comparing transplant centers in the U.S. is an extremely challenging process, explains Dr. Marco Mielcarek, medical director of the Adult Blood and Marrow Transplant Program at SCCA. There are so many variables that must be taken into account, including type of cancer and stage, the patients underlying medical problems and age, the type of transplant they undergo, and the source of the stem cells for the transplant. Each patient has a unique risk profile.

Although the process of comparing transplant centers can be challenging, the intensive analysis allows researchers to compare themselves to other centers, leading to improved outcomes. Additionally, the report provides patients and their families with valuable information necessary when evaluating where to go for treatment.

When you adjust for risk factors, our patients outcomes exceeded expectations over a three-year period, Dr. Mielcarek says, thats information that is helpful for patients to know when they are making important health care decisions with their families.

To arrive at its findings, CIBMTR independently examined the survival rates of 19,945 transplants performed to treat blood cancers at U.S. centers in the NMDP network. The most recent reporting period covered January 1, 2009 to December 31, 2011. During this three-year period, 762 allogeneic transplants were performed at SCCA. The report, published annually, is required by federal law and is designed to provide potential stem cell transplant recipients, their families, and the public with comparative survival rates among transplant centers.

See the original post here:
Bone Marrow Transplant Program at Seattle Cancer Care Alliance Recognized for Its One-Year Survival Rates

Recommendation and review posted by Bethany Smith

By Marcus Johnson

Stem cell researchers from Harvard have been able to turn patients skin cells into neurons that can be affected by early-onset Alzheimers. Experts believe that this will make it easier to gather the results of cells affected by the disease. It is also believed that the research will make the development of new treatments a faster process.

The research was published in the Human Molecular Genetics journal and headed by Tracy Young-Pearse. The data showed that peopl suffering from Alzheimers had cell mutations t similar to mutations occurring in mice. We see this mild increase in A42 in cells from patients with Alzheimer's disease, which seems to be enough to trigger disease processes, said Young-Pearse. We also see increases of a smaller species of amyloid-beta called A38, which was unexpected as it should not be very aggregation prone. We don't fully understand what it means, but it may combine with other forms of amyloid-beta to stimulate plaque formation.

The researchers hope that their work can lead to new drugs that are more effective against the disease. Alzheimers drugs have had a high rate of failure during clinical trials because much of the drug development was based on non-human models. Young-Pearse hopes that their research can make it easier to treat the disease and develop new drugs. Because of the Harvard Stem Cell Institute, we were able to work with other researchers to make patient cells into any type of neuron," said Young-Pearse. "The environment provides a really nice system for testing many kinds of hypotheses.

Read the rest here:
Stem Cells Driving Alzheimer's Research

Recommendation and review posted by Bethany Smith

(PRWEB) March 07, 2014

Dr. Vincent Giampapa, Co-founder and Chief Medical Offer of CellHealthTM Institute (CHI), will appear as a guest on A Healthy You and Carol Alt March 8th and 9th at 4pm EST on FOX. Dr. Giampapa and the former supermodel, healthy living expert and show host Carol Alt will explore the new technology of banking ones own adult stem cells for future use through CHIs new program, MyStemBank, http://www.MyStemBank.com. The show will dive deep into the real life needs for this new type of bio-insurance and will explain the ins and outs of the adult stem cell collection and storage process.

The human body is comprised of trillions of cells, which make up the skin, bones, muscles, tissues, and organs. They perform various, critical functions including transmitting signals, producing energy, and defending the body against illness. The mother of all of those cells is our adult stem cells.

Adult stem cells are the reservoir from which cells can be used now and in the future for both preventive health and disease treatment. The implications of this on our human health are tremendous, says Dr. Giampapa.

Tune in to learn about how this fascinating new preventive health practice is becoming as popular as cord blood storage and how MyStemBanks gold standard of adult stem cell collection differs from other types of collection.

Dr. Vincent Giampapa will also be a featured expert on Stem Cell Universe with Stephen Hawking, airing on Science Channel on March 13th, 9am PST/EST that will discuss in greater detail the importance of adult stem cell collection.

CellHealthTM Institute, a research based biotech company committed to developing and delivering the highest quality products and services that will enable and empower people to live healthier lives, longer. CHI is committed to developing and delivering high quality and high efficacy products to empower people to take control of their health at its most basic, cellular level. CHI collaborates with top-tier research universities and biotech companies to offer breakthrough nutritional supplements, lifestyle education, and fully integrated personalized health programs. CHI is also committed to pushing the limits of current medical practice to unlock the secrets of chronic illness, disease and aging by exploring the possibilities of advanced stem cell therapies.

For more information or press inquires please go to http://www.mystembank.com or call 844-709-7836.

Read the original:
CellHealth Institutes Dr. Vincent Giampapa Unveils MyStemBank: A Revolutionary Type of Adult Stem Cell Bio ...

Recommendation and review posted by Bethany Smith

21.Spinal Cord Injury(T5-6) Treated by Stem Cell Therapy(After)
After treatment: The patient received four times of stem cell treatment in our center. His overall condition improved a lot after the treatment. The injury l...

By: Cells Center China

Read the original here:
21.Spinal Cord Injury(T5-6) Treated by Stem Cell Therapy(After) - Video

Recommendation and review posted by Bethany Smith

Many people think of Gene Stratton-Porter as an avid naturalist and talented author who spent much of her time in the outdoors. But a new review of official records and newspaper reports of the day provides a fuller and sometimes conflicting picture of one of Indiana's most famous women.

Stratton-Porter, for example, spent a lot of time in Fort Wayne, often taking the train here to go shopping, visit family or attend social events and lectures, researcher Terri Gorney of Fort Wayne said.

While lamenting the draining of the Limberlost Swamp near Geneva, Gorney also found Stratton-Porter and her husband, Charles, had 30 or more oil wells on their 239-acre farm 3 miles west of town, which required draining the swamp to install the wells.

It's fun, because I never know where it's going to lead me, Gorney, 53, said of her search for information.

The News-Sentinel recently wrote about Gorney's research on early conservationists in northeast Indiana, which she started in 2007.

She began researching Stratton-Porter in 2009 at the suggestion of Randy Lehman, site manager for the Limberlost State Historic Site, the Porters' large log home in Geneva. Gorney had become active with the Friends of the Limberlost, a nonprofit group that supports the state historic site and efforts to restore wetlands once part of the Limberlost Swamp.

She didn't think she would find much new about Stratton-Porter. But when she really starting digging in 2011, she was surprised.

I'm still finding things, she said.

Gorney reads day by day through newspapers of the late 1800s and early 1900s in Fort Wayne, Geneva and Decatur. She also sifts through official land and other records, as well as archives containing letters Stratton-Porter wrote to other people.

She is pleased what she learns helps the Limberlost site and its historical interpretation of Stratton-Porter.

Link:
New research traces Fort Wayne ties of legendary naturalist, author Gene Stratton-Porter

Recommendation and review posted by Bethany Smith

Minecraft: TurtleCraft+ #4 W/ Dr.UNNAMED - Advance Genetics!
Download this Modpack @ http://www.technicpack.net/modpack/details/turtlecraft-by-thebutteryt.281020 DR.UNNAMED #39;s Youtube Channel: http://www.youtube.com/kri...

By: TheBUTTERY_T

Link:
Minecraft: TurtleCraft+ #4 W/ Dr.UNNAMED - Advance Genetics! - Video

Recommendation and review posted by Bethany Smith

2014 Zuoz, March 1: Steven Stone, Myriad Genetics, Salt Lake City, UT
The 8th Engadin Prostate Cancer Winter Symposium: Steven Stone, Salt Lake City, UT: New prognostic genetic markers for PCa More info @ http://web.oncoletter.ch/

By: oncoletter

Original post:
2014 Zuoz, March 1: Steven Stone, Myriad Genetics, Salt Lake City, UT - Video

Recommendation and review posted by Bethany Smith

AsuraGenetics - Genetics #1 (Multi-Cod) By Starzy Vulgar
Here it is! The 1st Insallment Of GENETICS!! 100 Likes?! Like, Comment Favorite to show your support! (Watch in 720p) [Open Description for Info!] Thank Yo...

By: AsuraGenetics

See the rest here:
AsuraGenetics - Genetics #1 (Multi-Cod) By Starzy & Vulgar - Video

Recommendation and review posted by Bethany Smith

Simple Mendelian genetics crossings
The laws of inheritance were derived by Gregor Mendel, a nineteenth-century Austrian monk conducting hybridization experiments in garden peas (Pisum sativum)...

By: GeneticsLessons

Read the original here:
Simple Mendelian genetics crossings - Video

Recommendation and review posted by Bethany Smith

Minecraft :: Genetics King! :: Attack of the B-Team E16
Minecraft Attack of the B-Team is a CRAZY modpack from technic with some really fun and off the wall mods. You can get the modpack here http://tinyurl.com/nu...

By: BdoubleO100

View original post here:
Minecraft :: Genetics King! :: Attack of the B-Team E16 - Video

Recommendation and review posted by Bethany Smith

Farmers are being urged to vote in favour of a genetics investment proposal that will bring together New Zealand's sheep and beef genetics in a new collaboration.

A successful vote would see the separate activities of Sheep Improvement Ltd, the Beef and Lamb New Zealand Central Progeny Test and Ovita, with added investment in beef genetics, become a new entity called Beef and Lamb New Zealand Genetics.

Total funding from government and industry sources would be up to $8.8 million a year.

Farmers were asked to reaffirm their current annual investment of $2.9 million, via Beef and Lamb New Zealand, ahead of the organisation's annual meeting next Friday. Neil Sanderson, an Angus New Zealand board member, representing the southern South Island, and a member of the association's breed development committee, was enthusiastic about the collaboration, saying the only way the industry would move forward was through science.

He believed it was a wonderful opportunity ''to fill in the gaps'' in knowledge relating to profitability in the beef industry, particularly in reproduction and fertility and also meat and carcass aspects.

While Mr Sanderson felt the current level of performance recording in the beef industry was quite good in the traits that could be measured easily, insight was needed into those traits that could not be measured, such as fertility, longevity and adaptability and suitability for hill-country environments.

Mr Sanderson believed the collaboration was a real opportunity for New Zealand to ''take the lead in its own destiny'', capitalising on the niche it had with its grass-fed and grass-finished beef.

It was exciting to see some of the processing companies offering significant premiums for recognising quality in the beef industry, which was scientifically based, not just anecdotally based.

That now needed to be linked in with genetics but finding and identifying those genetics with the current measuring system was not easy, he said.

Feedback from the programme needed to be utilised to try to link that to genetics.

Continued here:
Chance 'to fill in the gaps'

Recommendation and review posted by Bethany Smith

Accelerated Genetics will host its annual Leadership Conference, March 21-23, at the Three Bears Lodge in Warrens, Wis.

This event is designed for farm owners, herdspeople or employees seeking to acquire some leadership skills, and learn how to look at life with a new perspective.

This years conference titled Surviving the Jungle: A lesson in Leadership, is specifically tailored for emerging agricultural leaders who are positioned to lead the farm business and agricultural industry in the future.

Speakers Jolene Brown, Stan Erwine, and Jolene Griffin, Nate Janssen and Eliz Greene will be featured at the conference, along with educational and fun sessions created to help producers manage and lead their family, farm and cooperative in the future.

The conference offers an opportunity to sit back, spend time with others and enjoy time away from the home and farm business. Any dairy or beef farm owners, herdspeople or employees are eligible for this conference, and the event is designed for persons who have not previously attended. Accelerated Genetics believes the producer holds the key to the future and will be the agricultural leader of tomorrow.

To register, call 800-451-9275 or email ProducerProgram@accelgen.com. Registration deadline is March 10. Aconference flyer available at http://www.accelgen.com.

Visit link:
Accelerated Genetics sets Leadership Conference

Recommendation and review posted by Bethany Smith

Could gene therapy hold key in AIDS fight?
An experimental treatment for HIV at the University of Pennsylvania is using gene therapy to help prevent the virus from developing into AIDS. Doctors extrac...

By: CBS Evening News

See original here:
Could gene therapy hold key in AIDS fight? - Video

Recommendation and review posted by Bethany Smith

Personalized Medicine: A Decade of Progress by Jay Flatley, Illumina at PMWC 2014 SV
Speaker: Jay T. Flatley, President Chief Executive Officer, Illumina A retrospective on progress made in personalized medicine, an outline of where we are ...

By: pmwcInt1

See the article here:
Personalized Medicine: A Decade of Progress by Jay Flatley, Illumina at PMWC 2014 SV - Video

Recommendation and review posted by sam

Segment 1: The Benefits of Personalized Medicine
Personalized medicine is a term you hear a lot in life science discussions. Over the next few videos, Andrew Wiecek from Drug Discovery Development and I w...

By: BioscienceTechnology

More here:
Segment 1: The Benefits of Personalized Medicine - Video

Recommendation and review posted by sam